Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 719

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Mechanisms of probiotic actions – A review

Oelschlaeger, Tobias A.·2010·International Journal of Medical Microbiology
DOI 10.1016/j.ijmm.2009.08.005
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijmm.2009.08.005

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 50

  1. Altenhoefer, 2004, The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens, FEMS Immunol. Med. Microbiol., 40, 223, 10.1016/S0928-8244(03)00368-7 · DOI · Paper page
  2. Asahara, 2004, Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7, Infect. Immun., 72, 2240, 10.1128/IAI.72.4.2240-2247.2004 · DOI · Paper page
  3. Botes, 2008, Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments, Arch. Microbiol., 190, 573, 10.1007/s00203-008-0408-0 · DOI
  4. Braat, 2004, Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dentritic cell function, Am. J. Clin. Nutr., 80, 1618, 10.1093/ajcn/80.6.1618 · DOI · Paper page
  5. Carey, 2008, The effect of probiotics and organic acids on shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7, J. Microbiol. Methods, 73, 125, 10.1016/j.mimet.2008.01.014 · DOI
  6. Castagliuolo, 1996, Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum, Infect. Immun., 64, 5225, 10.1128/IAI.64.12.5225-5232.1996 · DOI · Paper page
  7. Chandra, 2008, Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-κB and MAPK signalling, Cell. Microbiol., 10, 1442, 10.1111/j.1462-5822.2008.01137.x · DOI · Paper page
  8. Cheikhyoussef, 2008, Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application, Int. J. Food Microbiol., 125, 215, 10.1016/j.ijfoodmicro.2008.03.012 · DOI
  9. Chen, 2006, Sacchamromyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis, J. Biol. Chem., 281, 24449, 10.1074/jbc.M605200200 · DOI
  10. Cleusix, 2008, Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces, FEMS Microbiol. Ecol., 63, 56, 10.1111/j.1574-6941.2007.00412.x · DOI
  11. Collado, 2007, Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa, Curr. Microbiol., 55, 260, 10.1007/s00284-007-0144-8 · DOI
  12. Elli, 2000, Iron requirement of Lactobacillus spp. in completely chemically defined growth media, J. Appl. Microbiol., 88, 695, 10.1046/j.1365-2672.2000.01013.x · DOI · Paper page
  13. Geier, 2006, Probiotics, prebiotics and synbiotics. A role in chemoprevention of colorectal cancer?, Cancer Biol. Ther., 5, 1265, 10.4161/cbt.5.10.3296 · DOI
  14. Golowczyc, 2007, Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis, Int. J. Food Microbiol., 118, 264, 10.1016/j.ijfoodmicro.2007.07.042 · DOI
  15. Grangette, 2005, Enhanced anti-inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids, Proc. Natl. Acad. Sci. USA, 102, 10321, 10.1073/pnas.0504084102 · DOI · Paper page
  16. Gratz, 2006, Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B1 in rats, Appl. Environ. Microbiol., 72, 7398, 10.1128/AEM.01348-06 · DOI
  17. Gratz, 2007, Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 cells, Appl. Environ. Microbiol., 73, 3958, 10.1128/AEM.02944-06 · DOI
  18. Große, 2006, A new ferrous iron-uptake transporter, EfeuU (YcdN), from Escherichia coli, Mol. Microbiol., 62, 120, 10.1111/j.1365-2958.2006.05326.x · DOI · Paper page
  19. Grozdanov, 2004, Analysis of the genome structure of the non-pathogenic probiotic Escherichia coli strain Nissle 1917, J. Bacteriol., 186, 5432, 10.1128/JB.186.16.5432-5441.2004 · DOI · Paper page
  20. Hess, 2004, A Salmonella fim homologue in Citrobacter freundii mediates invasion in vitro and crossing of the blood brain barrier in the rat pup model, Infect. Immun., 72, 5298, 10.1128/IAI.72.9.5298-5307.2004 · DOI
  21. Hirayama, 2000, The role of probiotic bacteria in cancer prevention, Microbes Infect., 2, 681, 10.1016/S1286-4579(00)00357-9 · DOI · Paper page
  22. Ingrassia, 2005, Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells, Appl. Environ. Microbiol., 71, 2880, 10.1128/AEM.71.6.2880-2887.2005 · DOI
  23. Kamada, 2008, Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells, Infect. Immun., 76, 214, 10.1128/IAI.01193-07 · DOI
  24. Kelly, 2004, Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA, Nat. Immunol., 5, 104, 10.1038/ni1018 · DOI · Paper page
  25. Kruis, 2004, Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine, Gut, 53, 1617, 10.1136/gut.2003.037747 · DOI · Paper page
  26. Lee, 2004, Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum, J. Vet. Sci., 5, 41, 10.4142/jvs.2004.5.1.41 · DOI · Paper page
  27. Mack, 2003, Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro, Gut, 52, 827, 10.1136/gut.52.6.827 · DOI · Paper page
  28. Macpherson, 2004, Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria, Science, 303, 1662, 10.1126/science.1091334 · DOI · Paper page
  29. Maqueda, 2008, Genetic features of circular bacteriocins produced by Gram-positive bacteria, FEMS Microbiol. Rev., 32, 2, 10.1111/j.1574-6976.2007.00087.x · DOI · Paper page
  30. Matsuo, 1997, Histochemistry of the surface mucous gel layer of the human colon, Gut, 40, 782, 10.1136/gut.40.6.782 · DOI · Paper page
  31. Nybom, 2008, Specific strains of probiotic bacteria are efficient in removal of several different cyanobacterial toxins from solution, Toxicon, 52, 214, 10.1016/j.toxicon.2008.04.169 · doi:10.1016/j.toxicon.2008.04.169
  32. O’Mahony, 2001, Probiotic impact on microbial flora, inflammation and tumor development in IL-10 knockout mice, Aliment. Pharmacol. Ther., 15, 1219, 10.1046/j.1365-2036.2001.01027.x · DOI · Paper page
  33. Paton, 2006, Designer probiotics for prevention of enteric infections, Nat. Rev. Microbiol., 4, 193, 10.1038/nrmicro1349 · DOI
  34. Petrof, 2004, Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition, Gastroenterology, 127, 1474, 10.1053/j.gastro.2004.09.001 · DOI · Paper page
  35. Qamar, 2001, Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice, Infect. Immun., 69, 2762, 10.1128/IAI.69.4.2762-2765.2001 · DOI
  36. Rachmilewitz, 2004, Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis, Gastroenterology, 126, 520, 10.1053/j.gastro.2003.11.019 · DOI · Paper page
  37. Roos, 2002, A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components, Microbiology, 148, 433, 10.1099/00221287-148-2-433 · DOI · Paper page
  38. Sanchez, 2008, Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host, FEMS Immunol. Med. Mirobiol., 54, 1, 10.1111/j.1574-695X.2008.00454.x · DOI
  39. Schlee, 2007, Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin, Infect. Immun., 75, 2399, 10.1128/IAI.01563-06 · DOI · Paper page
  40. Sheil, 2004, Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis, Gut, 53, 694, 10.1136/gut.2003.027789 · DOI
  41. Sun, 2005, Distinct immune response induced by peptidoglycan derived from Lactobacillus sp, World J. Gastroenterol., 11, 6330, 10.3748/wjg.v11.i40.6330 · DOI
  42. Takahashi, 2004, The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice, FEMS Immunol. Med. Microbiol., 41, 219, 10.1016/j.femsim.2004.03.010 · DOI · Paper page
  43. Takeda, 2006, Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota, Clin. Exp. Immunol., 146, 109, 10.1111/j.1365-2249.2006.03165.x · DOI · Paper page
  44. Tooley, 2006, Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats, Cancer Biol. Ther., 5, 593, 10.4161/cbt.5.6.2659 · DOI
  45. Turner, 2008, Lactobacillus rhamnosus strain GG restores alkaline phosphatase activity in differentiating Caco-2 cells dosed with the potent mycotoxin deoxynivalenol, Food Chem. Toxicol., 46, 2118, 10.1016/j.fct.2008.02.004 · DOI
  46. Van Guelpen, 2006, Low folate levels may protect against colorectal cancer, Gut, 55, 1461, 10.1136/gut.2005.085480 · DOI
  47. Wehkamp, 2004, NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression, Gut, 53, 1658, 10.1136/gut.2003.032805 · DOI · Paper page
  48. Wohlgemuth, 2010, Recent developments and perspectives in the investigation of probiotic effects, Int. J. Med. Microbiol., 300, 10.1016/j.ijmm.2009.08.003 · DOI
  49. Yan, 2007, Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth, Gastroenterology, 132, 562, 10.1053/j.gastro.2006.11.022 · DOI · Paper page
  50. Zyrek, 2007, Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKC redistribution resulting in tight junction and epithelial barrier repair, Cell. Microbiol., 9, 804, 10.1111/j.1462-5822.2006.00836.x · DOI · Paper page

Cited by

See all 719

Metadata

Authors
Oelschlaeger, T. A.
Venue
International Journal of Medical Microbiology
Publisher
Elsevier BV
Published
2010-01
Volume
300
Issue
1
Pages
57-62
ISSN
1438-4221 (ISSN-L)
DOI
10.1016/j.ijmm.2009.08.005
OpenAlex
W1975167841
Cited by
719
References
4
FWCI
34.00
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of probiotic actions – A review. https://app.cochat.ai/papers/10.1016/j.ijmm.2009.08.005
The paper
Oelschlaeger, T. A. (2010). Mechanisms of probiotic actions – A review. International Journal of Medical Microbiology. https://doi.org/10.1016/j.ijmm.2009.08.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.